![Gregory P. Dubé](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory P. Dubé
Chief Tech/Sci/R&D Officer at
Hemoglobin Oxygen Therapeutics LLC
Profile
Gregory P.
Dubé is currently working as the VP-Research & Development at Hemoglobin Oxygen Therapeutics LLC.
Previously, he worked as the Senior Director-Pre-Clinical & Clinical Programs at Thermalin, Inc. He completed his undergraduate degree at Northeastern University and obtained his doctorate degree from The University of Cincinnati College of Medicine.
Gregory P. Dubé active positions
| Companies | Position | Start |
|---|---|---|
Hemoglobin Oxygen Therapeutics LLC
 Hemoglobin Oxygen Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures hemoglobin-based oxygen products | Chief Tech/Sci/R&D Officer | - |
Former positions of Gregory P. Dubé
| Companies | Position | End |
|---|---|---|
Thermalin, Inc.
 Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Develops insulin treatments for patients with diabetes | Corporate Officer/Principal | - |
Training of Gregory P. Dubé
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
6
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Hemoglobin Oxygen Therapeutics LLC
Hemoglobin Oxygen Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures hemoglobin-based oxygen products | Health Technology |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Cincinnati College of Medicine
 The University of Cincinnati College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thermalin, Inc.
Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Develops insulin treatments for patients with diabetes | Health Technology |
- Stock Market
- Insiders
- Gregory P. Dubé
